Search
for
Sort by
Research 61–90 of 122
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Controllable Production of Transplantable Adult Human High-Passage Dermal Papilla Spheroids Using 3D Matrigel Culture
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Metformin and Malignant Tumors: Not Over the Hill
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Management of Dermatologic Toxicities
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Survey on adverse events associated with drug therapy for breast cancer patients
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors